CN101525333A - Synthesis method of metixene hydrochloride - Google Patents
Synthesis method of metixene hydrochloride Download PDFInfo
- Publication number
- CN101525333A CN101525333A CN200910048908A CN200910048908A CN101525333A CN 101525333 A CN101525333 A CN 101525333A CN 200910048908 A CN200910048908 A CN 200910048908A CN 200910048908 A CN200910048908 A CN 200910048908A CN 101525333 A CN101525333 A CN 101525333A
- Authority
- CN
- China
- Prior art keywords
- acid
- add
- cool
- thioxanthene
- dropwise
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- RAOHHYUBMJLHNC-UHFFFAOYSA-N methixene hydrochloride Chemical compound [H+].O.[Cl-].C1N(C)CCCC1CC1C2=CC=CC=C2SC2=CC=CC=C21 RAOHHYUBMJLHNC-UHFFFAOYSA-N 0.000 title description 2
- 238000001308 synthesis method Methods 0.000 title 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims abstract description 38
- XESBUBZPORIQAV-UHFFFAOYSA-N 2-phenylbenzenecarbothioic s-acid Chemical compound OC(=S)C1=CC=CC=C1C1=CC=CC=C1 XESBUBZPORIQAV-UHFFFAOYSA-N 0.000 claims abstract description 31
- YRHRIQCWCFGUEQ-UHFFFAOYSA-N thioxanthen-9-one Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3SC2=C1 YRHRIQCWCFGUEQ-UHFFFAOYSA-N 0.000 claims abstract description 30
- PQJUJGAVDBINPI-UHFFFAOYSA-N 9H-thioxanthene Chemical compound C1=CC=C2CC3=CC=CC=C3SC2=C1 PQJUJGAVDBINPI-UHFFFAOYSA-N 0.000 claims abstract description 29
- NBOMNTLFRHMDEZ-UHFFFAOYSA-N thiosalicylic acid Chemical compound OC(=O)C1=CC=CC=C1S NBOMNTLFRHMDEZ-UHFFFAOYSA-N 0.000 claims abstract description 17
- 229940103494 thiosalicylic acid Drugs 0.000 claims abstract description 11
- FFOIFAAVWJZLFE-UHFFFAOYSA-N 3-(chloromethyl)-1-methylpiperidine Chemical compound CN1CCCC(CCl)C1 FFOIFAAVWJZLFE-UHFFFAOYSA-N 0.000 claims abstract description 8
- YCOXTKKNXUZSKD-UHFFFAOYSA-N as-o-xylenol Natural products CC1=CC=C(O)C=C1C YCOXTKKNXUZSKD-UHFFFAOYSA-N 0.000 claims abstract description 8
- SNHMUERNLJLMHN-UHFFFAOYSA-N iodobenzene Chemical compound IC1=CC=CC=C1 SNHMUERNLJLMHN-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims abstract description 5
- 230000009467 reduction Effects 0.000 claims abstract description 5
- 230000018044 dehydration Effects 0.000 claims abstract description 4
- 238000006297 dehydration reaction Methods 0.000 claims abstract description 4
- 238000006798 ring closing metathesis reaction Methods 0.000 claims abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 32
- 239000007787 solid Substances 0.000 claims description 28
- 238000003756 stirring Methods 0.000 claims description 19
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 18
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical group CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 15
- 238000006243 chemical reaction Methods 0.000 claims description 15
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical group C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 12
- 239000002904 solvent Substances 0.000 claims description 12
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 claims description 11
- 239000002244 precipitate Substances 0.000 claims description 11
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- 239000003054 catalyst Substances 0.000 claims description 9
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 claims description 8
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical group [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 claims description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 7
- 239000003513 alkali Substances 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- 239000003960 organic solvent Substances 0.000 claims description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 6
- 239000012024 dehydrating agents Substances 0.000 claims description 6
- 150000007530 organic bases Chemical class 0.000 claims description 6
- 238000010791 quenching Methods 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 5
- -1 lithium aluminum hydride Chemical compound 0.000 claims description 5
- 239000012279 sodium borohydride Substances 0.000 claims description 5
- 229910000033 sodium borohydride Inorganic materials 0.000 claims description 5
- 238000000967 suction filtration Methods 0.000 claims description 5
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 4
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 claims description 4
- 229920006395 saturated elastomer Polymers 0.000 claims description 4
- 229910021595 Copper(I) iodide Inorganic materials 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 claims description 3
- 239000012280 lithium aluminium hydride Substances 0.000 claims description 3
- 229920000137 polyphosphoric acid Polymers 0.000 claims description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 3
- 229910021589 Copper(I) bromide Inorganic materials 0.000 claims description 2
- 229910021591 Copper(I) chloride Inorganic materials 0.000 claims description 2
- 238000006482 condensation reaction Methods 0.000 claims description 2
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 claims description 2
- NKNDPYCGAZPOFS-UHFFFAOYSA-M copper(i) bromide Chemical group Br[Cu] NKNDPYCGAZPOFS-UHFFFAOYSA-M 0.000 claims description 2
- 229940045803 cuprous chloride Drugs 0.000 claims description 2
- 238000010189 synthetic method Methods 0.000 claims description 2
- 230000015572 biosynthetic process Effects 0.000 abstract description 13
- 238000003786 synthesis reaction Methods 0.000 abstract description 13
- 238000000034 method Methods 0.000 abstract description 11
- 230000008569 process Effects 0.000 abstract description 6
- 229940035678 anti-parkinson drug Drugs 0.000 abstract description 3
- 230000002194 synthesizing effect Effects 0.000 abstract description 3
- AESPYQQDASDLHC-UHFFFAOYSA-N 2h-benzo[g]thiochromene Chemical compound C1=CC=C2C=C(C=CCS3)C3=CC2=C1 AESPYQQDASDLHC-UHFFFAOYSA-N 0.000 abstract description 2
- 230000008878 coupling Effects 0.000 abstract description 2
- 238000010168 coupling process Methods 0.000 abstract description 2
- 238000005859 coupling reaction Methods 0.000 abstract description 2
- 238000002360 preparation method Methods 0.000 abstract description 2
- 239000000047 product Substances 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 229940125782 compound 2 Drugs 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- TVWWSIKTCILRBF-UHFFFAOYSA-N molybdenum trisulfide Chemical compound S=[Mo](=S)=S TVWWSIKTCILRBF-UHFFFAOYSA-N 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 208000027776 Extrapyramidal disease Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 229940126214 compound 3 Drugs 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229940043279 diisopropylamine Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- BMNDJWSIKZECMH-UHFFFAOYSA-N nitrosyl bromide Chemical compound BrN=O BMNDJWSIKZECMH-UHFFFAOYSA-N 0.000 description 1
- 239000010815 organic waste Substances 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000003087 receptor blocking agent Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
一种盐酸麦塞散的合成方法,涉及一种抗震颤麻痹药的合成工艺。本发明以硫代水杨酸为原料经过与碘苯的偶联得到2-苯硫基苯甲酸,然后再脱水关环得到9-噻吨酮,再经过羰基还原得到硫杂蒽,最后硫杂蒽与3-氯甲基-1-甲基哌啶反应得到如下式的目标产物(5)盐酸麦塞散。本发明原料易得,成本价廉,制备路线短,操作简单,易于工业化,所得的盐酸麦塞散是一种抗震颤麻痹药。
The invention discloses a method for synthesizing Methasan hydrochloride, which relates to a synthesis process of an anti-parkinsonian drug. The present invention uses thiosalicylic acid as a raw material to obtain 2-phenylthiobenzoic acid through coupling with iodobenzene, then dehydration and ring closure to obtain 9-thioxanthone, and then carbonyl reduction to obtain thioxanthene, and finally thia Anthracene reacts with 3-chloromethyl-1-methylpiperidine to obtain the target product (5) Methasan hydrochloride of the following formula. The raw materials of the invention are easy to obtain, the cost is low, the preparation route is short, the operation is simple, and the industrialization is easy.
Description
技术领域 technical field
一种盐酸麦塞散的合成方法,涉及一种抗震颤麻痹药的合成工艺,属于医药制备技术领域A method for synthesizing mesai powder hydrochloride, relating to a synthesis process of an anti-parkinsonian drug, belonging to the technical field of pharmaceutical preparation
背景技术 Background technique
盐酸麦塞散是抗震颤麻痹药,又名盐酸美噻吨(metixene hydrochloride)是一种M受体阻滞药,用于治疗帕金森病,包括缓解药源性锥体外系综合征.美国专利US2905590,报道了其合成方法是以硫杂蒽和3-氯甲基-1-甲基哌啶在碱的作用下缩合,再经过盐酸酸化得到盐酸麦塞散,但该方法用到毒性大的苯和容易燃烧的钠,不利于工业化。2-苯硫基苯甲酸的合成在许多文献中报道过,但都采用有机溶剂,造成环境污染,不符合绿色化学的要求。而9-噻吨酮(3)经过羰基还原得到硫杂蒽(4)的过程中,Takido,Toshio(Journal of HeterocyclicChemistry(1995),32(2),687-90.)报道了用三硫化钼作催化剂,在氢气环境下还原,但三硫化钼价格昂贵,而且反应要在氢气环境下进行,这就对反应设备提高了要求,不利于工业化.Methasan hydrochloride is an anti-parkinsonian drug, also known as metixene hydrochloride, which is an M-receptor blocker, used for the treatment of Parkinson's disease, including alleviating drug-induced extrapyramidal syndrome. US Patent US2905590 reports that its synthetic method is to condense thioxanthene and 3-chloromethyl-1-methylpiperidine under the effect of alkali, and then obtain Methasan hydrochloride through hydrochloric acid acidification, but this method uses the large toxic Benzene and easily flammable sodium are not conducive to industrialization. The synthesis of 2-phenylthiobenzoic acid has been reported in many literatures, but all of them use organic solvents, which cause environmental pollution and do not meet the requirements of green chemistry. And 9-thioxanthone (3) was obtained in the process of thioxanthene (4) through carbonyl reduction, Takido, Toshio (Journal of Heterocyclic Chemistry (1995), 32 (2), 687-90.) reported the use of molybdenum trisulfide As a catalyst, it can be reduced in a hydrogen environment, but molybdenum trisulfide is expensive, and the reaction must be carried out in a hydrogen environment, which raises the requirements for the reaction equipment, which is not conducive to industrialization.
发明内容 Contents of the invention
本发明的目的在于公开一种原料易得,成本低廉,制备路线短,操作简单,易于工业化的盐酸麦塞散的合成工艺。The purpose of the present invention is to disclose a kind of raw material is easy to obtain, and cost is low, and preparation route is short, and operation is simple, and the synthesis process of mesai powder hydrochloride that is easy to industrialize.
为了达到上述目的,我们采用水作溶剂,避免了有机废液的产生。本发明以硫代水杨酸为原料经过与碘苯的偶联得到2-苯硫基苯甲酸,然后再脱水关环得到9-噻吨酮,再经过羰基还原得到硫杂蒽,最后硫杂蒽与3-氯甲基-1-甲基哌啶缩合反应得到如下式的目标产物盐酸麦塞散(5)。具体工艺按如下4步进行In order to achieve the above purpose, we use water as solvent to avoid the generation of organic waste liquid. The present invention uses thiosalicylic acid as a raw material to obtain 2-phenylthiobenzoic acid through coupling with iodobenzene, then dehydration and ring closure to obtain 9-thioxanthone, and then carbonyl reduction to obtain thioxanthene, and finally thia Anthracene and 3-chloromethyl-1-methylpiperidine are condensed to obtain the target product Methasan hydrochloride (5) of the following formula. The specific process is carried out in the following 4 steps
第一步在催化剂作用下将硫代水杨酸(1)与碘苯发生偶联反应,得到2-苯硫基苯甲酸(2)In the first step, thiosalicylic acid (1) is coupled with iodobenzene under the action of a catalyst to obtain 2-phenylthiobenzoic acid (2)
先将碱和溶剂H2O配成摩尔浓度为1.3~3.2mol/L的碱溶液,冷至室温,N2保护下,将硫代水杨酸(1)加到碱溶液中,搅拌0.5~1h,加入催化剂和碘苯,升温至90℃~110℃反应12-30小时,停止加热,冷至室温,用盐酸调PH值为1,抽滤得到黄色固体,洗涤、烘干得白色固体2-苯硫基苯甲酸(2);First prepare the base and the solvent H2O to form a base solution with a molar concentration of 1.3-3.2 mol/L, cool to room temperature, add thiosalicylic acid (1) into the base solution under the protection of N2 , and stir for 0.5-3.2 mol/L 1h, add catalyst and iodobenzene, heat up to 90℃~110℃ and react for 12-30 hours, stop heating, cool to room temperature, adjust pH value to 1 with hydrochloric acid, obtain yellow solid by suction filtration, wash and dry to obtain white solid 2 - phenylthiobenzoic acid (2);
上述投料量的摩尔比为硫代水杨酸∶催化剂∶碱=1∶0.01~0.2∶2~5;The mol ratio of above-mentioned charging amount is thiosalicylic acid: catalyst: alkali=1: 0.01~0.2: 2~5;
上述催化剂为溴化亚铜、碘化亚铜或氯化亚铜;碱为氢氧化钾或氢氧化钠;Above-mentioned catalyst is cuprous bromide, cuprous iodide or cuprous chloride; Alkali is potassium hydroxide or sodium hydroxide;
第二步,2-苯硫基苯甲酸(2)经过脱水关环得到9-噻吨酮(3)In the second step, 2-phenylthiobenzoic acid (2) undergoes dehydration and ring closure to obtain 9-thioxanthone (3)
N2保护下,将2-苯硫基苯甲酸(2)与脱水剂混合,加热至100℃~160℃,搅拌反应5~12小时,冷至室温后倒入水中抽滤得灰绿色固体,固体用水洗涤,烘干,丙酮提取两次,旋干溶剂得到黄色固体9-噻吨酮(3);Under the protection of N2 , mix 2-phenylthiobenzoic acid (2) with a dehydrating agent, heat to 100°C-160°C, stir and react for 5-12 hours, cool to room temperature, pour into water and filter with suction to obtain a gray-green solid. The solid was washed with water, dried, extracted twice with acetone, and the solvent was spin-dried to obtain a yellow solid 9-thioxanthone (3);
上述脱水剂为浓硫酸或多聚磷酸;Above-mentioned dehydrating agent is concentrated sulfuric acid or polyphosphoric acid;
上述投料量的质量比为2-苯硫基苯甲酸∶脱水剂=1∶5~10;The mass ratio of above-mentioned charging amount is 2-phenylthiobenzoic acid: dehydrating agent=1: 5~10;
第三步,9-噻吨酮(3)经过羰基还原得到硫杂蒽(4)In the third step, 9-thioxanthone (3) undergoes carbonyl reduction to obtain thioxanthene (4)
先量取9-噻吨酮∶硼氢化钠或四氢铝锂∶氯化铝=1∶1~5∶1~5摩尔比,然后N2保护下,将溶剂却至0℃~5℃后将硼氢化钠或四氢铝锂加入,保持0℃~5℃再将9-噻吨酮(3)加入后搅拌1h,然后将氯化铝用溶剂溶解后慢慢滴加其中,滴加完后,加热至20℃~80℃,搅拌8h,冷却至2℃~5℃,慢慢滴加2N HCl或水淬灭反应,抽滤,烘干得到白色沉淀为硫杂蒽(4);First measure 9-thioxanthone: sodium borohydride or lithium aluminum hydride: aluminum chloride = 1: 1 ~ 5: 1 ~ 5 molar ratio, then under the protection of N2 , cool the solvent to 0 ° C ~ 5 ° C Add sodium borohydride or lithium aluminum tetrahydride, keep at 0°C~5°C, then add 9-thioxanthone (3) and stir for 1 hour, then dissolve aluminum chloride in a solvent and add it slowly, until the dropwise addition is complete Afterwards, heat to 20°C to 80°C, stir for 8 hours, cool to 2°C to 5°C, slowly add 2N HCl or water dropwise to quench the reaction, filter with suction, and dry to obtain a white precipitate as thioxanthene (4);
上述溶剂为乙腈或乙醚;Above-mentioned solvent is acetonitrile or ether;
第四步,硫杂蒽(4)与3-氯甲基-1-甲基哌啶缩合反应得到盐酸麦塞散(5)The fourth step, thioxanthene (4) and 3-chloromethyl-1-methylpiperidine condensation reaction to obtain Methasan hydrochloride (5)
无水无氧下将硫杂蒽(4)溶于无水有机溶剂,降温至-78℃~0℃,滴加有机碱,继续保持冰盐浴搅拌1h,滴加3-氯甲基-1-甲基哌啶,滴加完恢复至室温,反应8-12h,冰浴冷却至0℃~5℃缓慢滴加加入饱和NH4Cl溶液淬灭反应,抽滤,沉淀用有机溶剂洗涤,滤液旋干得黄色固液混合物,固液混合物以乙醇溶解,再滴入浓盐酸,搅拌15min,加入甲基叔丁基醚,冰浴冷析出大量白色固体,为盐酸麦塞散(5);Dissolve thioxanthene (4) in anhydrous organic solvent under anhydrous and oxygen-free conditions, cool down to -78°C to 0°C, add organic base dropwise, keep stirring in ice-salt bath for 1 hour, add 3-chloromethyl-1 dropwise -Methylpiperidine, return to room temperature after the dropwise addition, react for 8-12h, cool in an ice bath to 0°C-5°C, slowly add saturated NH 4 Cl solution dropwise to quench the reaction, filter with suction, wash the precipitate with an organic solvent, and the filtrate Spin dry to obtain a yellow solid-liquid mixture, dissolve the solid-liquid mixture with ethanol, add concentrated hydrochloric acid dropwise, stir for 15 minutes, add methyl tert-butyl ether, and cool in an ice bath to precipitate a large amount of white solid, which is Methasan hydrochloride (5);
上述有机溶剂为四氢呋喃;Above-mentioned organic solvent is THF;
上述有机碱为正丁基锂或二异丙基胺基锂;The above-mentioned organic base is n-butyllithium or lithium diisopropylamide;
上述投料量的摩尔比为硫杂蒽∶3-氯甲基-1-甲基哌啶∶有机碱=1∶1~6∶1~6。The molar ratio of the above-mentioned feeding amount is thioxanthene: 3-chloromethyl-1-methylpiperidine: organic base=1:1~6:1~6.
本发明的优点如下:The advantages of the present invention are as follows:
1.本发明的原料硫代水杨酸和碘苯是市场购得,来源广泛,价格低廉,特别是在第一步合成2-苯硫基苯甲酸的过程中选用水作溶剂,符合绿色化学的要求,成本低无污染.1. raw material thiosalicylic acid of the present invention and iodobenzene are purchased in the market, and source is extensive, and price is cheap, especially selects water as solvent in the process of synthesizing 2-phenylthiobenzoic acid in the first step, accords with green chemistry requirements, low cost and no pollution.
2.本发明合成路线较短,方法简单,操作方便,具有较高的工业化生产的实用价值2. The synthesis route of the present invention is relatively short, the method is simple, the operation is convenient, and it has higher practical value in industrialized production
3.本发明所用的催化剂和还原剂的价格便宜,容易得到,因此生产成本有了较大的降低3. The catalyst used in the present invention and reductant are cheap and easy to obtain, so the production cost has been greatly reduced
具体实施方式 Detailed ways
实施例1Example 1
2-苯硫基苯甲酸(2)的合成Synthesis of 2-phenylthiobenzoic acid (2)
将KOH(54.5g,972.7mmol)和600ml H2O配成溶液,冷至室温。N2保护下,将原料硫代水杨酸(30g,389.1mmol)加入到1000ml三颈瓶中,以上面所配的KOH溶液溶解加热至60℃搅拌30分钟,N2保护下加入溴化亚铜(1.675g,11.6mmol),加入碘苯,升温至回流,反应20h,停止加热,反应液冷至室温,滴加浓盐酸100ml滴加时间为30min,PH值为1,有大量黄色固体生成,抽滤得黄色固体,用2×500ml水洗涤沉淀,得白色固体,烘干得目标产物2-苯硫基苯甲酸(2)85.5g产率95.5%KOH (54.5 g, 972.7 mmol) and 600 ml H 2 O were made into a solution, and cooled to room temperature. Under the protection of N 2 , the raw material thiosalicylic acid (30 g, 389.1 mmol) was added into a 1000 ml three-necked flask, dissolved in the KOH solution prepared above and heated to 60° C. and stirred for 30 minutes, and then added with nitrous bromide under the protection of N 2 Copper (1.675g, 11.6mmol), add iodobenzene, heat up to reflux, react for 20h, stop heating, cool the reaction solution to room temperature, add 100ml of concentrated hydrochloric acid dropwise for 30min, pH value is 1, a large amount of yellow solids are formed , obtained a yellow solid by suction filtration, washed the precipitate with 2×500ml water to obtain a white solid, and dried to obtain the target product 2-phenylthiobenzoic acid (2) 85.5g yield 95.5%
1HNMR(500MHz,CDCl3)8.2~8.4(d,1H),7.7~7.8(t,2H)7.5~7.6(t,3H),7.3~7.4(t,1H),7.2~7.3(t,1H),6.7~6.8(d,1H) 1 HNMR (500MHz, CDCl 3 ) 8.2~8.4(d, 1H), 7.7~7.8(t, 2H), 7.5~7.6(t, 3H), 7.3~7.4(t, 1H), 7.2~7.3(t, 1H) ), 6.7~6.8(d, 1H)
9-噻吨酮(3)的合成Synthesis of 9-thioxanthone (3)
N2保护下依次将化合物2(65.3g,283.5mmol)及多聚磷酸300ml,加入到1000ml三颈瓶中,加热至150℃,搅拌8h,将反应液冷至室温,慢慢倒入到2000ml水中抽滤得灰绿色固体,固体用1000ml洗涤,将固体烘干,将烘干的固体用2×1000ml丙酮提取两次,旋干溶剂得到黄色固体,烘干得9-噻吨酮(3)55.5g,产率92.8%Under the protection of N2, compound 2 (65.3g, 283.5mmol) and 300ml of polyphosphoric acid were added to a 1000ml three-necked flask, heated to 150°C, stirred for 8h, and the reaction solution was cooled to room temperature, and slowly poured into a 2000ml Suction filter in water to obtain a gray-green solid, wash the solid with 1000ml, dry the solid, extract the dried solid with 2×1000ml acetone twice, spin the solvent to obtain a yellow solid, and dry to obtain 9-thioxanthone (3) 55.5g, yield 92.8%
1HNMR(500MHz,CDCl3)7.4~7.5(m,2H),7.6~7.7(m,4H),8.6~8.7(m,2H) 1 HNMR (500MHz, CDCl 3 ) 7.4~7.5(m, 2H), 7.6~7.7(m, 4H), 8.6~8.7(m, 2H)
硫杂蒽(4)的合成Synthesis of Thioxanthene (4)
N2保护下,将无水乙腈135ml加入到1000ml三颈瓶中,冰浴冷却至0-5℃将硼氢化钠(7.22,190.8mmol)加入到三颈瓶中,保持冰浴,N2保护下将9-噻吨酮(3)(27.0g,127.2mmol)加入到三颈瓶中,加完后保持冰浴搅拌1h,称取三氯化铝(17.0g,127.2mmol)于锥形瓶中用90ml无水乙腈溶解,保持冰浴,将三氯化铝的乙腈溶液慢慢滴加到三颈瓶中,滴加完后,撤去冰浴,加热至40℃,搅拌8h,冰浴冷却体系至0-5℃,慢慢滴加150ml 2N HCl,抽滤,得白色沉淀,沉淀用100ml 2N HCl洗涤,烘干得到产品硫杂蒽(4)20.2g产率80.0%.1HNMR(500MHz,CDCl3)7.5~7.6(t,2H)7.3~7.4(d,2H),7.1~7.2(m,4H)3.8(s,2H)Under the protection of N2 , add 135ml of anhydrous acetonitrile into a 1000ml three-necked flask, cool in an ice bath to 0-5°C, add sodium borohydride (7.22, 190.8mmol) into the three-necked flask, keep it in an ice bath, and protect it under N2 Next, add 9-thioxanthone (3) (27.0g, 127.2mmol) into the three-necked flask, keep stirring in an ice bath for 1h after the addition, and weigh aluminum trichloride (17.0g, 127.2mmol) in the Erlenmeyer flask Dissolve in 90ml of anhydrous acetonitrile, keep the ice bath, slowly add the acetonitrile solution of aluminum trichloride into the three-necked bottle, after the dropwise addition, remove the ice bath, heat to 40°C, stir for 8h, and cool in the ice bath When the system was brought to 0-5°C, 150ml 2N HCl was slowly added dropwise, and suction filtered to obtain a white precipitate. The precipitate was washed with 100ml 2N HCl, and dried to obtain 20.2g of the product Thioxanthene (4). The yield was 80.0%. 1 HNMR (500MHz , CDCl 3 ) 7.5~7.6(t, 2H) 7.3~7.4(d, 2H), 7.1~7.2(m, 4H) 3.8(s, 2H)
盐酸麦塞散(5)的合成Synthesis of Methasan Hydrochloride (5)
无水无氧操作,将化合物4(11.3g,56.9mol)溶于100ml无水四氢呋喃,加入到250ml三颈瓶中。冰盐浴降温至-10℃~0℃,滴加正丁基锂(27.5ml,2.5M),继续保持冰盐浴搅拌1h保持冰盐浴滴加3-氯甲基-1-甲基哌啶(8.0g,54.2mmol)。滴加完撤去冰盐浴,恢复至室温,反应12h,冰浴冷却体系至0-5℃缓慢滴加加入2ml饱和NH4Cl溶液淬灭反应,抽滤,沉淀用15ml四氢呋喃洗涤,滤液旋干得黄色固液混合物。混合物以200ml乙醇溶解,再加入10ml浓盐酸,搅拌15min,加入500ml甲基叔丁基醚,冰浴冷析出大量白色固体,得化合物盐酸麦塞散(5)14.4g,产率76.8%Anhydrous and oxygen-free operation, compound 4 (11.3g, 56.9mol) was dissolved in 100ml of anhydrous tetrahydrofuran, and added to a 250ml three-necked flask. Cool the ice-salt bath to -10°C to 0°C, add n-butyllithium (27.5ml, 2.5M) dropwise, keep stirring in the ice-salt bath for 1h, and add 3-chloromethyl-1-methylpiperone dropwise in the ice-salt bath Pyridine (8.0 g, 54.2 mmol). Remove the ice-salt bath after the dropwise addition, return to room temperature, react for 12 hours, cool the system in an ice bath to 0-5°C, slowly add 2ml of saturated NH 4 Cl solution dropwise to quench the reaction, filter with suction, wash the precipitate with 15ml of tetrahydrofuran, and spin the filtrate to dry A yellow solid-liquid mixture was obtained. The mixture was dissolved in 200ml of ethanol, then 10ml of concentrated hydrochloric acid was added, stirred for 15min, 500ml of methyl tert-butyl ether was added, and a large amount of white solid was precipitated by ice-bath cooling to obtain 14.4g of the compound Methiasan hydrochloride (5), with a yield of 76.8%
1HNMR(500MHz,CDCl3)7.1~7.5(m,8H),4.1(t,3H),3.4(d,1H),3.0(d,1h),2.6(m,3H),2.4(m,1H),2.3(m,2H),2.1(m,1H),1.8(m,2H),1.7(m,2H),1.0(m,1H) 1 HNMR (500MHz, CDCl 3 ) 7.1~7.5(m, 8H), 4.1(t, 3H), 3.4(d, 1H), 3.0(d, 1h), 2.6(m, 3H), 2.4(m, 1H) ), 2.3(m, 2H), 2.1(m, 1H), 1.8(m, 2H), 1.7(m, 2H), 1.0(m, 1H)
实施例2Example 2
2-苯硫基苯甲酸(2)的合成Synthesis of 2-phenylthiobenzoic acid (2)
将KOH(54.5g,972.7mmol)和600ml H2O配成溶液,冷至室温。N2保护下,将原料硫代水杨酸(1)(30g,389.1mmol)加入到1000ml三颈瓶中,以上面所配的KOH溶液溶解加热至60℃搅拌30分钟,N2保护下加入碘化亚铜(2.2g,11.6mmol),加入碘苯,升温至回流,反应20h,停止加热,反应液冷至室温,滴加浓盐酸100ml滴加时间为30min,PH值为1,有大量黄色固体生成,抽滤得黄色固体,用2×500ml水洗涤沉淀,得白色固体,烘干得目标产物2-苯硫基苯甲酸(2)85.5g产率95.5%KOH (54.5 g, 972.7 mmol) and 600 ml H 2 O were made into a solution, and cooled to room temperature. Under the protection of N2 , add the raw material thiosalicylic acid (1) (30g, 389.1mmol) into a 1000ml three-neck flask, dissolve it with the KOH solution prepared above, heat it to 60°C and stir for 30 minutes, then add it under the protection of N2 Cuprous iodide (2.2g, 11.6mmol), add iodobenzene, heat up to reflux, react for 20h, stop heating, cool the reaction solution to room temperature, add 100ml of concentrated hydrochloric acid dropwise for 30min, the pH value is 1, and there is a large amount of A yellow solid was formed, and the yellow solid was obtained by suction filtration, and the precipitate was washed with 2×500ml of water to obtain a white solid, which was dried to obtain 85.5 g of the target product 2-phenylthiobenzoic acid (2) with a yield of 95.5%
9-噻吨酮(3)的合成Synthesis of 9-thioxanthone (3)
N2保护下依次将化合物2(65.3g,283.5mmol)及浓硫酸300ml,加入到1000ml三颈瓶中,加热至100℃,搅拌8h,将反应液冷至室温,慢慢倒入到2000ml冰水中抽滤黄色固体,固体用1000ml洗涤,将固体烘干得9-噻吨酮(3)50.0g,产率83.6%Add compound 2 (65.3g, 283.5mmol) and concentrated sulfuric acid 300ml into a 1000ml three-neck flask in turn under N2 protection, heat to 100°C, stir for 8h, cool the reaction solution to room temperature, and slowly pour it into a 2000ml ice Suction filter the yellow solid in water, wash the solid with 1000ml, and dry the solid to obtain 50.0g of 9-thioxanthone (3), with a yield of 83.6%
硫杂蒽(4)的合成Synthesis of Thioxanthene (4)
N2保护下,将无水乙醚20ml加入到50ml三颈瓶中,冰浴冷却至0-5℃将四氢铝锂(0.6g,17.6mmol)加入到三颈瓶中,保持冰浴,N2保护下将化合物3(2.5g,11.75mmol)加入到三颈瓶中,加完后保持冰浴搅拌1h,称取三氯化铝(1.6g,11.75mmol)用9ml无水乙醚溶解,保持冰浴,将AlCl3的乙醚溶液慢慢滴加到三颈瓶中,滴加完后,撤去冰浴,加热至40℃,搅拌8h,冰浴冷却体系至0-5℃,慢慢滴加15ml水,15ml 15%NaOH溶液,抽滤,滤液浓缩得白色沉淀,烘干得到产品硫杂蒽(4)21.5g,产率85.0%Under the protection of N2 , add 20ml of anhydrous diethyl ether into a 50ml three-necked flask, cool in an ice bath to 0-5°C, add lithium aluminum hydride (0.6g, 17.6mmol) into a three-necked flask, keep in an ice bath, N Add compound 3 (2.5g, 11.75mmol) into a three-necked flask under the protection of 2 , keep stirring in an ice bath for 1h after the addition, weigh aluminum trichloride (1.6g, 11.75mmol) and dissolve it with 9ml of anhydrous ether, keep In an ice bath, slowly add the ether solution of AlCl 3 into the three-neck flask dropwise. After the dropwise addition, remove the ice bath, heat to 40°C, stir for 8 hours, cool the system to 0-5°C in an ice bath, and slowly add dropwise 15ml of water, 15ml of 15% NaOH solution, suction filtration, the filtrate was concentrated to give a white precipitate, dried to obtain 21.5g of product thioxanthene (4), yield 85.0%
盐酸麦塞散(5)的合成Synthesis of Methasan Hydrochloride (5)
无水无氧操作,将10.6ml二异丙胺溶于100ml无水四氢呋喃,加入到250ml三颈瓶中。降温至-78℃,滴加正丁基锂(68.3mmol,27.5ml,2.5M),滴完保持-78℃搅拌1h,氮气保护下将化合物硫杂蒽4(11.3g,56.9mmol)加入到反应瓶中,搅拌30分钟,滴加3-氯甲基-1-甲基哌啶(8.0g,54.2mmol)。滴加完恢复至室温,反应12h,冰浴冷却体系至0-5℃缓慢滴加加入2ml饱和NH4Cl溶液淬灭反应,抽滤,沉淀用15ml四氢呋喃洗涤,滤液旋干得黄色固液混合物。混合物以200ml乙醇溶解,再加入10ml浓盐酸,搅拌15min,加入500ml甲基叔丁基醚,冰浴冷析出大量白色固体,得化合物盐酸麦塞散(5)15.0g,产率80%For anhydrous and oxygen-free operation, dissolve 10.6ml of diisopropylamine in 100ml of anhydrous tetrahydrofuran and add it to a 250ml three-necked bottle. Cool down to -78°C, add n-butyllithium (68.3mmol, 27.5ml, 2.5M) dropwise, keep stirring at -78°C for 1h after dropping, and add compound Thioxanthene 4 (11.3g, 56.9mmol) into In the reaction flask, stirred for 30 minutes, and 3-chloromethyl-1-methylpiperidine (8.0 g, 54.2 mmol) was added dropwise. Return to room temperature after the dropwise addition, react for 12 hours, cool the system in an ice bath to 0-5°C, slowly add 2ml of saturated NH 4 Cl solution dropwise to quench the reaction, filter with suction, wash the precipitate with 15ml of tetrahydrofuran, and spin the filtrate to obtain a yellow solid-liquid mixture . The mixture was dissolved in 200ml of ethanol, then 10ml of concentrated hydrochloric acid was added, stirred for 15min, 500ml of methyl tert-butyl ether was added, and a large amount of white solid was precipitated by cooling in an ice bath to obtain 15.0g of the compound Mesaisan hydrochloride (5), with a yield of 80%
1HNMR(500MHz,CDCl3)7.1~7.5(m,8H),4.1(t,3H),3.4(d,1H),3.0(d,1h),2.6(m,3H),2.4(m,1H),2.3(m,2H),2.1(m,1H),1.8(m,2H),1.7(m,2H),1.0(m,1H)。 1 HNMR (500MHz, CDCl 3 ) 7.1~7.5(m, 8H), 4.1(t, 3H), 3.4(d, 1H), 3.0(d, 1h), 2.6(m, 3H), 2.4(m, 1H) ), 2.3(m, 2H), 2.1(m, 1H), 1.8(m, 2H), 1.7(m, 2H), 1.0(m, 1H).
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100489089A CN101525333B (en) | 2009-04-07 | 2009-04-07 | A kind of synthetic method of Methiasan hydrochloride |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100489089A CN101525333B (en) | 2009-04-07 | 2009-04-07 | A kind of synthetic method of Methiasan hydrochloride |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101525333A true CN101525333A (en) | 2009-09-09 |
CN101525333B CN101525333B (en) | 2011-04-27 |
Family
ID=41093428
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009100489089A Expired - Fee Related CN101525333B (en) | 2009-04-07 | 2009-04-07 | A kind of synthetic method of Methiasan hydrochloride |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101525333B (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105859653A (en) * | 2016-04-29 | 2016-08-17 | 嘉兴学院 | Quetiapine synthesizing method |
CN110818682A (en) * | 2019-11-07 | 2020-02-21 | 盐城市大丰区天生联合药业有限公司 | Preparation method of isopropyl thioxanthone |
CN113666908A (en) * | 2021-08-23 | 2021-11-19 | 江西高信前沿科技有限公司 | Preparation process for producing food-grade benzoic acid by adopting photosensitive catalyst |
WO2025053518A1 (en) * | 2023-09-06 | 2025-03-13 | 재단법인대구경북과학기술원 | Composition for treating kidney diseases comprising metixene or pharmaceutically acceptable salt thereof |
-
2009
- 2009-04-07 CN CN2009100489089A patent/CN101525333B/en not_active Expired - Fee Related
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105859653A (en) * | 2016-04-29 | 2016-08-17 | 嘉兴学院 | Quetiapine synthesizing method |
CN105859653B (en) * | 2016-04-29 | 2018-12-14 | 嘉兴学院 | A kind of synthetic method of Quetiapine |
CN110818682A (en) * | 2019-11-07 | 2020-02-21 | 盐城市大丰区天生联合药业有限公司 | Preparation method of isopropyl thioxanthone |
CN113666908A (en) * | 2021-08-23 | 2021-11-19 | 江西高信前沿科技有限公司 | Preparation process for producing food-grade benzoic acid by adopting photosensitive catalyst |
WO2025053518A1 (en) * | 2023-09-06 | 2025-03-13 | 재단법인대구경북과학기술원 | Composition for treating kidney diseases comprising metixene or pharmaceutically acceptable salt thereof |
Also Published As
Publication number | Publication date |
---|---|
CN101525333B (en) | 2011-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101525333B (en) | A kind of synthetic method of Methiasan hydrochloride | |
CN107200832A (en) | A kind of polymer with aggregation-induced emission effect and preparation method thereof, graphene composite material and preparation method thereof | |
CN101787042A (en) | Copper-nitrogen compound and application thereof | |
CN103936656B (en) | A kind of preparation method of 4-bromine carbazole | |
CN111057087B (en) | A kind of asymmetric thiophene [7] helicene isomer and its preparation method and application | |
CN103159763A (en) | Novel perylene bisimide type photoelectric function material and synthetic method thereof | |
CN104311593A (en) | Synthesis method of mono functional group octa-polysilsesquioxane | |
CN104119354B (en) | A kind of cross benzo two thiophene compound and preparation method thereof | |
CN118598813B (en) | L-malic acid salsa Mi Duofen and preparation method thereof | |
CN105461737A (en) | Bis(1,3-dithiol-2-carbonyl) fused naphthyl imide derivative and synthesis method thereof | |
CN107501301B (en) | Diseleno[2,3-b:3′,2′-d]selenophene and preparation method thereof | |
CN111747923B (en) | Crown ether carboxylic acid compound-containing BPDC-12-C-4 and preparation method and application thereof | |
CN108997299A (en) | A kind of organic room temperature phosphorimetry material of efficient and long life and preparation method thereof | |
CN1321989C (en) | AE-active ester chemical synthesizing method | |
CN103073467B (en) | Preparation method of alpha-carbonyl sulfur ylide derivative | |
CN105693737B (en) | A class of bipyridine ligands with axial chirality and their synthesis | |
CN114213424B (en) | Synthesis method of furan [3,2-b ] pyridine derivative | |
CN106543215A (en) | A kind of dinaphtho thiophene coughs up organic photoelectric functional material and its synthetic method | |
TWI576349B (en) | Manufacturing method of borinic acid derivatives and novel borinic acid derivatives | |
CN101747343B (en) | A kind of preparation method of sulbactam pivoxil | |
CN103601741B (en) | A kind of 2,1,3-diazosulfide 1,4-Dithiapentalene derivative and synthetic method thereof | |
CN102391170B (en) | A kind of preparation method of N, N-diallyl-5-methoxytryptamine hydrochlorides | |
CN101607914A (en) | Simple method for preparing to tert-butyl benzyl amine | |
CN106892936B (en) | A kind of synthetic method of secondary trifluoromethyl propargyl alcohol | |
JP2016150928A (en) | Method for producing compound |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110427 Termination date: 20140407 |